IMBRIA Trademark

Trademark Overview

On Wednesday, November 14, 2018, a trademark application was filed for IMBRIA with the United States Patent and Trademark Office. The USPTO has given the IMBRIA trademark a serial number of 88193544. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Imbria Pharmaceuticals, Inc.. The IMBRIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development for pharmaceuticals
imbria

General Information

Serial Number88193544
Word MarkIMBRIA
Filing DateWednesday, November 14, 2018
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7287486
Registration DateTuesday, January 23, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesResearch and development for pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 1, 2018
Primary Code042
First Use Anywhere DateWednesday, March 31, 2021
First Use In Commerce DateWednesday, March 31, 2021

Trademark Owner History

Party NameImbria Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NameImbria Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NameImbria Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 25, 2023USE AMENDMENT FILED
Monday, November 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 25, 2023SOU EXTENSION 1 FILED
Monday, October 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 25, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, May 27, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 22, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, April 12, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 24, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, August 6, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 5, 2020ASSIGNED TO LIE
Thursday, January 30, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, June 24, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 24, 2019LETTER OF SUSPENSION E-MAILED
Monday, June 24, 2019SUSPENSION LETTER WRITTEN
Friday, June 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 14, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 13, 2019ASSIGNED TO LIE
Friday, June 7, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 20, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 20, 2019LETTER OF SUSPENSION E-MAILED
Wednesday, February 20, 2019SUSPENSION LETTER WRITTEN
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Saturday, December 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 17, 2018NEW APPLICATION ENTERED

Related Keywords

imbria pharmaceuticals development research